Health and Medicine

News about UB’s health sciences programs and related community outreach. (see all topics)

Meet an Expert

UB alum Lawrence Tabak named acting NIH director
12/16/21
UB alumnus Lawrence Tabak has been named the acting director of the NIH by U.S. Secretary of Health and Human Services Xavier Becerra.
UB receives nearly $735,000 to expand dental care for patients with disabilities in WNY
12/13/21
Funding will help resume and expand a previous initiative between the UB School of Dental Medicine and nonprofit Arc GLOW that provided dental care to patients with disabilities in the university’s mobile dental clinic.
UB receives $2.3 million grant to help prevent life-threatening drug interactions
12/7/21
The NIH-funded research will examine how tyrosine kinases affect the removal of drugs by the liver.
Four UB life sciences spinoffs receive new NIH funding
12/7/21
The startups are advancing projects that could help fight diseases ranging from COVID-19 to cancer to diabetes.
AI-powered computer model predicts disease progression during aging
12/7/21
Using artificial intelligence, a team of UB researchers has developed a novel system that uses metabolic and cardiovascular biomarkers to model health status and disease risks across a patient’s lifespan.
UB’s Elad Levy selected as president of the Congress of Neurological Surgeons
12/6/21
Elad I. Levy, MD, professor and chair of the Department of Neurosurgery, has been named president-elect of the Congress of Neurological Surgeons (CNS).
Nursing dean Marsha Lewis to retire
12/3/21
Lewis has guided the School of Nursing through 10 years of growth in its core mission of education, research and community service.
Study: Older MS patients who discontinue medications experience worsening of their disease
12/2/21
A new study provides evidence that discontinuing medications in older and previously stable MS patients results in new disease worsening/progression.
Study: How to freeze-dry a potential COVID-19 vaccine
12/1/21
In Science Advances, scientists report successfully freeze-drying specialized liposomes that could be developed for use in future vaccines.
Inhaled steroid keeps COVID-19 patients with mild to moderate disease out of the hospital
11/22/21
A national study has found that patients with mild to moderate COVID-19 who are treated with an inhaled steroid are significantly less likely to require emergency department care or hospitalization due to COVID-19 than those treated with placebo.